ContraVir Pharma (CTRV) Reports Acceptance of Clinical Trial Application in the U.K,
Tweet Send to a Friend
ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV) announced today that the Clinical Trial Application (CTA) for the formulation optimization clinical program for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
